Cardiovascular risk factor assessment in late-onset seizures: A study protocol to assess the value of structured intervention.
David Larsson, Signild Åsberg, Johan Sundström...
https://pubmed.ncbi.nlm.nih.gov/38874366/Actively Recruiting
Led by Sahlgrenska University Hospital · Updated on 2026-03-03
420
Participants Needed
3
Research Sites
391 weeks
Total Duration
Researchers are studying people who have their first unprovoked seizures after the age of 50 to understand whether screening and managing vascular risk factors can reduce the risk of stroke and other cardiovascular problems. This observational study includes a cluster design combining a one-year prospective clinical study and a long-term register-based cohort study. The goal is to see if vascular risk assessments should be part of care for late-onset seizures and to evaluate the effects of such screening on a system-wide level. Participants at selected sites will undergo vascular risk factor screening that includes medical history, blood pressure checks, body measurements, blood tests, and lifestyle assessments. The prospective clinical part follows participants for one year after screening to monitor management and outcomes. Meanwhile, a register study will track all patients at participating sites over at least 5 to 10 years to compare long-term effects against historic controls. During the study, patients will have assessments including blood pressure, cholesterol levels, HbA1c, ECG, kidney function, and urine albumin-to-creatinine ratio, among others. Researchers will measure how many patients receive pharmacological interventions within one year and review secondary outcomes at recruitment and one year. The observational data and long-term follow-up will help understand the impact of vascular risk management after late-onset seizures.
CONDITIONS
Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment
J
Johan Zelano, MD PhD
D
David Larson, MD PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Sahlgrenska University Hospital
Lead Sponsor
Sodra Alvsborgs Hospital
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - At recruitment
Participants undergo vascular risk factor screening including blood pressure, medical history, BMI, and laboratory tests.
1 visit (in-person)
Duration - At least 5 to 10 years
Participants are followed in registers for at least 5 to 10 years to observe health outcomes and treatment effects.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
David Larsson, Signild Åsberg, Johan Sundström...
https://pubmed.ncbi.nlm.nih.gov/38874366/Sahlgrenska University Hospital
Lead Sponsor
Sodra Alvsborgs Hospital
Collaborating Sponsor